Clinical Trial Update: TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome) [Phase 3]

View source ↗

Summary

Phase 3 TELESTAR trial evaluating telotristat etiprate for carcinoid syndrome completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Syndrome

Drugs mentioned

• Telotristat Etiprate (telotristat etiprate)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Carcinoid Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2017-09-18